Case Study: Allogeneic Invariant Natural Killer T-Cells: Approaches for Solid Tumor Treatment
Time: 11:30 am
day: Conference Day One
Details:
- Why iNKT cells are a highly effective and efficient platform for allogeneic cell therapy
- Which approaches does MiNK Therapeutics pursue for the development of solid tumor therapy?
- Recent MiNK preclinical and clinical data on ongoing programs
